Liu, Bingcheng
Wang, Ying
Zhou, Chunlin
Wei, Hui
Lin, Dong
Li, Wei
Liu, Kaiqi
Zhang, Guangji
Wei, Shuning
Li, Yan
Gong, Benfa
Liu, Yuntao
Gong, Xiaoyuan
Mi, Yingchang
Wang, Jianxiang
Funding for this research was provided by:
State Key Program of National Natural Science of China (81430004)
Tianjin Clinical Research Center for Blood Diseases (15ZXLCSY00010)
National Natural Science Foundation of China (81670159)
Natural Science Foundation of Tianjin (15JCYBJC25700, 15JCYBJC25000)
Article History
Received: 28 May 2018
Accepted: 1 January 2019
First Online: 11 January 2019
Compliance with ethical standards
:
: The authors declare that they have no competing interest.
: The patients provided the required written informed consent. All procedures were conducted according to the Declaration of Helsinki. The study was approved by the local ethics committee of the Chinese Academy of Medical Sciences and Blood Diseases Hospital (Approval Number: YL2011032201). This trial was registered as ChiCTR-ONC-12002469.
: Informed consent was obtained from all individual participants included in the study.